Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Cardiac PET May Help Reduce Use of Angiograms and Bypass Surgery

By HospiMedica staff writers
Posted on 13 Aug 2007
A recent study has shown that positron emission tomography (PET) scanning, when used as the first tool to diagnose heart-vessel blockages, is more accurate, less invasive, and less expensive than single photon emission computed tomography (SPECT) imaging. More...


The study's findings were published in the July 2007 issue of the Journal of Nuclear Medicine. Results of the study, performed by investigators from the State University of New York at Buffalo (UB; USA), provide a rationale for PET scanning to become the initial diagnostic test for assessing a patient's risk of heart attack, according to lead researcher Michael Merhige, M.D., UB clinical associate professor of nuclear medicine and director of the Heart Center of Niagara at Niagara Falls Memorial Medical Center (NY, USA). "Because PET scanning is more accurate and provides a clearer picture of the state of the heart than conventional SPECT imaging, we found a decrease in the use of angiograms and bypass surgery by more than 50% if used as the first-line test with patients when all too often it is the last test.”

Dr. Merhige added, "Currently, cardiologists conduct a range of tests, including stress tests and an imaging procedure called single photon emission computed tomography, or SPECT. False readings from SPECT often put patients through angiograms that turn out to be normal. PET avoids most false-positives, as well as false-negatives, because the images have higher resolution and better contrast.”

Dr. Merhige's study, incorporating PET technology, demonstrates that invasive procedures such as coronary arteriography, coronary bypass surgery, and stent implantation are overused in the United States, contributing to unnecessary healthcare expense without improved patient outcomes. Furthermore, the study supports the idea that the future of cardiology lies in non-invasive imaging combined with the aggressive use of cholesterol lowering drugs and lifestyle changes including better nutrition, regular exercise, and smoking cessation.

Dr. Merhige's study concluded that significant lifestyle changes--very low-fat diet, exercise, cholesterol-lowering drugs, and stress management--are essential for successful medical management. Dr. Merhige commented, "For some patients, surgery seems like a quicker option, when it actually only addresses symptoms, not the underlying disease process.”


Related Links:
State University of New York at Buffalo

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.